Related Experiment Videos
Ventricular enlargement following a myocardial infarction
Journal of Cardiovascular Pharmacology
|January 1, 1987
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Filtration Markers, Cardiovascular Disease, Mortality, and Kidney Outcomes in Stable Kidney Transplant Recipients: The FAVORIT Trial.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
Is a reduction in albuminuria associated with renal and cardiovascular protection? A post hoc analysis of the ALTITUDE trial.
Diabetes, obesity & metabolism·2015
Characteristics of a model of myocardial infarction produced by coronary artery ligation in the rat.
Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
Departures from the protocol during conduct of a clinical trial: a pattern from the data record consistent with a learning curve.
Quality & safety in health care·2010
Lovastatin decreases acute mucosal inflammation via 15-epi-lipoxin A4.
Mucosal immunology·2010
Empagliflozin Reduces Post-Myocardial Infarction Inflammation via BDH1/β-Hydroxybutyrate-Mediated NF-κB Modulation in Macrophages and the Heart.
Journal of cardiovascular pharmacology·2026
Machine Learning Models Integrating CYP2C19 Genotypes for Long-Term Risk Prediction and Personalized Antiplatelet Therapy Selection in Myocardial Infarction.
Journal of cardiovascular pharmacology·2026
Prednisone in the Management of Pericarditis A Systematic Review.
Journal of cardiovascular pharmacology·2026
Safety and Efficacy of Colchicine for the Treatment of Pericarditis in Patients with Chronic Kidney Disease.
Journal of cardiovascular pharmacology·2026
The Subclinical Window for Cardioprotection in Duchenne Muscular Dystrophy: A Systematic Review and Meta-analysis.
Journal of cardiovascular pharmacology·2026
Incretin-based therapies, alcohol and tobacco use, and acute substance-related events: emerging implications for cardiovascular medicine.
Journal of cardiovascular pharmacology·2026